6.00
Ss Innovations International Inc stock is traded at $6.00, with a volume of 85,417.
It is up +6.01% in the last 24 hours and down -44.19% over the past month.
See More
Previous Close:
$5.66
Open:
$6.18
24h Volume:
85,417
Relative Volume:
2.26
Market Cap:
$1.16B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.50%
1M Performance:
-44.19%
6M Performance:
+0.00%
1Y Performance:
+0.00%
Ss Innovations International Inc Stock (SSII) Company Profile
Name
Ss Innovations International Inc
Sector
Industry
Phone
-
Address
-
Compare SSII with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SSII
Ss Innovations International Inc
|
6.00 | 1.17B | 0 | 0 | 0 | 0.00 |
![]()
ABT
Abbott Laboratories
|
133.94 | 231.14B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
102.83 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
383.10 | 146.12B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
87.00 | 105.64B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.77 | 45.60B | 5.54B | 4.18B | 623.10M | 7.00 |
Ss Innovations International Inc Stock (SSII) Latest News
Proud Moment for India: SS Innovations Rings Nasdaq Opening Bell, Showcases Indian Medtech Excellence on Global Stage - udaipurkiran.com
Indian medtech start-up SS Innovations makes Nasdaq debut, showcasing global leadership in robotic surgery - eHealth Magazine
Indian medtech startup SSII celebrates debut on Nasdaq - News9live
SS Innovations International rings Nasdaq opening bell, putting Indian medtech on the global map - Healthcare Radius
SS Innovations Unveils New Strategic Expansion Plans - TipRanks
SS Innovations International Inc Rings the Opening Bell - Nasdaq
SS Innovations Rings Nasdaq Bell After Uplisting - TipRanks
SS Innovations International, Inc. to Ring Nasdaq Opening Bell Celebrating Uplisting and Milestone Surgeries - Nasdaq
SS Innovations to Ring the Nasdaq Opening Bell on Tuesday, June 3, 2025 - GlobeNewswire
Medical Robotics Breakthrough: SS Innovations Hits 4,000 Surgery Milestone as it Joins Nasdaq - Stock Titan
SS Innovations reaches 4,000 robotic surgeries with SSi Mantra robotic system - The Robot Report
SS Innovations International Becomes Oversold (SSII) - Nasdaq
SSII Unchanged on Developments in Robotics - Baystreet.ca
SS Innovations Hits 4,000 Surgeries Milestone - TipRanks
SS Innovations Surpasses Milestone of 4,000 Robotic - GlobeNewswire
Surgical Robot Achieves Perfect Safety Record Across 4,000 Operations Including Remote Heart Surgeries - Stock Titan
SS Innovations appoints new CEO for Asia Pacific By Investing.com - Investing.com Nigeria
SS Innovations appoints new CEO for Asia Pacific - Investing.com Australia
SS Innovations revenue jumps 40.8% to USD 5.1M in Q1 2025 - Medical Buyer
SS Innovations Reports Record Q1 Revenue Growth - TipRanks
SS Innovations International, Inc. Reports Record Quarterly Revenue of $5.1 Million, Driven by Increased SSi Mantra 3 Sales and Plans for FDA De Novo Application - Nasdaq
Earnings Flash (SSII) SS Innovations International Posts Q1 Revenue $5.1M - marketscreener.com
SS Innovations Reports First Quarter 2025 Financial Results - The Manila Times
SS Innovations to submit de novo classification request for surgical robotic system - Yahoo Finance
SS Innovations to seek FDA approval for robotic system By Investing.com - Investing.com Nigeria
SS Innovations reiterates guidance for Q1 2025 - MSN
SS Innovations to Submit De Novo Application to the FDA for - GlobeNewswire
SS Innovations Plans FDA Submission for Robotic System - TipRanks
SS Innovations to seek FDA approval for robotic system - Investing.com
SS Innovations to Submit De Novo Application to the FDA for the SSi Mantra 3 Surgical Robotic ... - Bluefield Daily Telegraph
SS Innovations to Submit De Novo Application to the FDA for the SSi Mantra 3 Surgical Robotic System for Multiple Indications - Stock Titan
SS Innovations Reports Surge in April 2025 Orders - TipRanks
SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends - The Manila Times
SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second ... - Bluefield Daily Telegraph
SS Innovations Reiterates Guidance for First Quarter 2025 - GlobeNewswire
Surgical Robot Orders Surge 200%: SS Innovations Reveals Strong Q1 Performance and Record-Breaking April Sales - Stock Titan
SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting - The Globe and Mail
SS Innovations names interim CFO amid leadership change By Investing.com - Investing.com Nigeria
SS Innovations Announces CFO Transition - marketscreener.com
SS Innovations Appoints Arvind Palaniappan as Interim CFO - TipRanks
SS Innovations names interim CFO amid leadership change - Investing.com
SS Innovations Announces Chief Financial Officer Transition - GlobeNewswire
Surgical Robotics Leader SS Innovations Appoints New CFO After Major Nasdaq Milestone - Stock Titan
SS Innovations International, Inc., Makers Of SSI Mantra, Makes Historic NASDAQ Debut - BW Healthcare World
SS Innovations International, Inc., Makers of SSI Mantra, Makes Historic NASDAQ Debut - areporterlive.com
Indian medical tech global - Udaipur Kiran
SS Innovations NASDAQ debut - udaipurkiran.com
SSII Stock Price and Chart — NASDAQ:SSII - TradingView
SS Innovations International listed on US exchange Nasdaq - The Economic Times
SS Innovations to Uplist to Nasdaq - Stock Titan
SS Innovations International, Inc. SEC 10-K Report - TradingView
Ss Innovations International Inc Stock (SSII) Financials Data
There is no financial data for Ss Innovations International Inc (SSII). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Cap:
|
Volume (24h):